BioLife Solutions, Inc. (BLFS) Stock Grade

About BioLife Solutions, Inc.'s fundamentals

BioLife Solutions is a healthcare company with a $1.9 billion market capitalization that has achieved 17.0% year-over-year revenue growth, demonstrating expanding commercial traction in its medical instruments and supplies business. However, the company is currently unprofitable, with a -12.6% net margin and a reported net loss in its latest annual statement, resulting in a P/E ratio of 41.1 that reflects investors' expectations for future profitability. Despite the accounting losses, the company generated positive free cash flow, suggesting that underlying operational cash generation supports the business even as it invests heavily in growth. The company does not currently pay a dividend.